We use cookies in order to analyze traffic of this website. Your further use of this website will be considered consent. For more information visit our Cookie Policy.


AC Immune’s investors are knowledgeable about life sciences and share the company’s commitment to developing state of the art solutions to the treatment of neurodegenerative diseases. Their oversight, guidance and support have proved an invaluable resource to AC Immune’s management. Together we have sought to make the most efficient and productive use of AC Immune’s capital to ensure the timely development of therapeutic products for which there is a critical need.
Investors interested in the company should please contact: ir@acimmune.com